Premium
A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy
Author(s) -
Goedee H. S.,
Jongbloed B. A.,
Asseldonk J.T. H.,
Hendrikse J.,
Vrancken A. F. J. E.,
Franssen H.,
Nikolakopoulos S.,
Visser L. H.,
Pol W. L.,
Berg L. H.
Publication year - 2017
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.13380
Subject(s) - medicine , multifocal motor neuropathy , magnetic resonance imaging , brachial plexus , hyperintensity , mismatch negativity , radiology , chronic inflammatory demyelinating polyneuropathy , neuroimaging , surgery , electroencephalography , psychiatry , antibody , immunology
Background and purpose To compare the performance of neuroimaging techniques, i.e. high‐resolution ultrasound ( HRUS ) and magnetic resonance imaging ( MRI ), when applied to the brachial plexus, as part of the diagnostic work‐up of chronic inflammatory demyelinating neuropathy ( CIDP ) and multifocal motor neuropathy ( MMN ). Methods Fifty‐one incident, treatment‐naive patients with CIDP ( n = 23) or MMN ( n = 28) underwent imaging of the brachial plexus using (i) a standardized MRI protocol to assess enlargement or T2 hyperintensity and (ii) bilateral HRUS to determine the extent of nerve (root) enlargement. Results We found enlargement of the brachial plexus in 19/51 (37%) and T2 hyperintensity in 29/51 (57%) patients with MRI and enlargement in 37/51 (73%) patients with HRUS . Abnormal results were only found in 6/51 (12%) patients with MRI and 12/51 (24%) patients with HRUS. A combination of the two imaging techniques identified 42/51 (83%) patients. We found no association between age, disease duration or Medical Research Council sum‐score and sonographic nerve size, MRI enlargement or presence of T2 hyperintensity. Conclusions Brachial plexus sonography could complement MRI in the diagnostic work‐up of patients with suspected CIDP and MMN . Our results indicate that combined imaging studies may add value to the current diagnostic consensus criteria for chronic inflammatory neuropathies.